Surgery
Volume 146, Issue 5 , Pages 896-905 , November 2009

Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy

  • Jingyu Deng, MD

      Affiliations

    • Department of Gastric Cancer Surgery, City Key Laboratory of Tianjin Cancer Center, Tianjin Medical University General Hospital, Tianjin, China
    • ,
  • Han Liang, MD

      Affiliations

    • Department of Gastric Cancer Surgery, City Key Laboratory of Tianjin Cancer Center, Tianjin Medical University General Hospital, Tianjin, China
    • Corresponding Author InformationReprint requests: Han Liang, MD, Gastric Oncology Division, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin, China.
    • ,
  • Dan Sun, MS

      Affiliations

    • Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China
    • ,
  • Yi Pan, MD

      Affiliations

    • Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China
    • ,
  • Baogui Wang, MD

      Affiliations

    • Department of Gastric Cancer Surgery, City Key Laboratory of Tianjin Cancer Center, Tianjin Medical University General Hospital, Tianjin, China
    • ,
  • Yuhong Guo, MD

      Affiliations

    • Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China

,Accepted 30 April 2009.

References 

  1. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285
  2. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 2002;16:922–934
  3. He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta. 2004;1654:3–12
  4. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573–583
  5. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16:773–783
  6. Sleeman JP. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res. 2000;1654:3–12
  7. Nadja E, Tobler , Michael D. Tumor and lymph node lymphangiogenesis—impact on cancer metastasis. J Leuk Biol. 2006;80:691–696
  8. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789–801
  9. Wilge JT, Oliver C. PROX-1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769–778
  10. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385–394
  11. Soker S, Takashima S, Miao H, Neufeld G, Klagsbrun M. Neuropilin is expressed by endothelial and tumor cells as isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735–745
  12. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996;15:290–298
  13. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA. 1996;93:11675–11680
  14. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 2000;60:203–212
  15. Hormbrey E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D, et al. A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?. Clin Exp Metastasis. 2002;19:651–663
  16. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis. 2007;38:256–268
  17. Moreira IS, Fernandes PA, Ramos MJ. Vascular endothelial growth factor (VEGF) inhibition—a critical review. Anticancer Agents Med Chem. 2007;7:223–245
  18. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964–3968
  19. Beck LJ, D'Amore P. Vascular development: cellular and molecular regulation. FASEB J. 1997;11:365–373
  20. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:14–25
  21. Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, et al. Micro-vessel density is a prognostic marker of human gastric cancer. World J Gastroenterol. 2006;12:7598–7603
  22. Zhou Y, Ran J, Tang C, Wu J, Honghua L, Xingwen L, et al. Effect of celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in gastric cancer. Cancer Biol Ther. 2007;6:269–275
  23. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, et al. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg. 2002;236:37–42
  24. Oh SY, Kwon HC, Kim SH, Jang JS, Kim MC, Kim KH, et al. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer. 2008;8:123
  25. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673–700
  26. Alitalo K, Carmelier P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 2002;1:219–227
  27. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med. 2001;7:186–191
  28. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423–1425
  29. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 2005;7:121–127
  30. Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003;314:167–177
  31. Thiele W, Sleeman JP. Tumor-induced lymphangiogenesis: a target for cancer therapy?. J Biotechnol. 2006;124:224–241
  32. Shiozawa N, Kodama M, Chida T, Arakawa A, Tur GE, Koyama K. Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology. 1994;41:244–247
  33. Folli S, Dente M, Dell'Amore D, Gaudio M, Nanni O, Saragoni L, et al. Early gastric cancer: prognostic factors in 223 patients. Br J Surg. 1995;82:952–956
  34. Kumagai K, Tanaka T, Yamagata K, Yokoyama N, Shimizu K. Liver metastasis in gastric cancer with particular reference to lymphatic advancement. Gastric Cancer. 2001;4:150–155
  35. Deng JY, Liang H, Sun D, Zhan HJ, Zhang RP. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol. 2008;14:2440–2447
  36. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg. 1994;81:1175–1178
  37. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol. 1997;92:490–493
  38. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis—impact on cancer metastasis. J Leukoc Biol. 2006;80:691–696
  39. Deng JY, Liang H, Liu N. Zhang Rupeng, Zhan Hongjie. Analysis of relative factors in hepatic metastasis from gastric cancer after radical gastrectomy. Zhonghuaputongwaikezazhi. 2007;22:739–742
  40. White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 2002;62:1669-75
  41. Achen MG, Mann GB, Stacker SA. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer. 2006;94:1355–1360
  42. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131:225–234
  43. Achen MG, Williams RA, Minekus MP, Thornton GE, Stenvers K, Rogers PAW, et al. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumor angiogenesis. J Pathol. 2001;193:147–154
  44. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, et al. Flt-4-positive vessel density correlates with vascular endothelial growth factor-D expression, nodal status, and prognosis in breast cancer. Clin Cancer Res. 2003;9:5313–5317
  45. Miyata Y, Kanda S, Ohba K, Nomata K, Hayashida Y, Eguchi J, et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implication and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res. 2006;12:800–806
  46. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S, Aikou T. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res. 2004;10:8413–8420
  47. Ji RC. Lymph node lymphangiogenesis: a new concept for modulating tumor metastasis and inflammatory process. Histol Histopathol. 2009;24:377–384
  48. Ishikawa M, Kitayama J, Kazama S, Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol. 2003;33:21–27
  49. Shida A, Fujioks S, Ishibashi Y, Kobayashi K, Nimura H, Mitsumori N, et al. Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. World J Surg. 2005;29:1600–1607
  50. Shida A, Fujioks S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N, et al. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol. 2006;11:38–43
  51. Yasuoka H, Nakamura Y, Zuo H, Tang W, Takamura Y, Miyauchi A, et al. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol. 2005;18:1127–1133
  52. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 2004;95:32–39
  53. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer. 2003;88:237–244
  54. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, et al. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res. 2003;9:1361–1369
  55. Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 2006;24:228–240
  56. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, Arima H, et al. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol. 2009;99:148–153
  57. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995;92:3566–3570
  58. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, et al. VEGFR-3 in adult angiogenesis. J Pathol. 2001;195:490–497
  59. Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002;62:7059–7065
  60. Yonemura Y, Fushida S, Bando E, Kinoshita K, Miwa K, Endo Y, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 2001;37:918–923
  61. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676
  62. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000;19:5598–5605
  63. López de Cicco R, Watson JC, Bassi DE, Litwin S, Klein-Szanto AJ. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. Clin Cancer Res. 2004;10:4480–4488

PII: S0039-6060(09)00299-2

doi: 10.1016/j.surg.2009.04.025

Surgery
Volume 146, Issue 5 , Pages 896-905 , November 2009

Article Tools

* Image Usage & Resolution